{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:19:34Z","timestamp":1780384774208,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA025032"],"award-info":[{"award-number":["R01DA025032"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000117"],"award-info":[{"award-number":["UL1TR000117"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.pbb.2014.11.018","type":"journal-article","created":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T04:53:41Z","timestamp":1417323221000},"page":"45-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine"],"prefix":"10.1016","volume":"129","author":[{"given":"William W.","family":"Stoops","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lon R.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig R.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2014.11.018_bb0005","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pbb.2012.09.025","article-title":"Alternative reinforcer response cost impacts methamphetamine choice in humans","volume":"103","author":"Bennett","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2014.11.018_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2008.03.001","article-title":"The role of human drug self-administration procedures in the development of medications","volume":"96","author":"Comer","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2014.11.018_bb0015","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1038\/npp.2013.143","article-title":"Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers","volume":"38","author":"Comer","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2014.11.018_bb0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pnpbp.2011.12.014","article-title":"Rivastigmine reduces \u201cLikely to use methamphetamine\u201d in methamphetamine-dependent volunteers","volume":"37","author":"De La Garza","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2014.11.018_bb0025","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/sj.npp.1301481","article-title":"Bupropion for the treatment of methamphetamine dependence","volume":"33","author":"Elkashef","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2014.11.018_bb0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbr.2008.08.021","article-title":"The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat","volume":"197","author":"H\u00e4ggkvist","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2014.11.018_bb0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-008-1079-x","article-title":"Controversies in translational research: drug self-administration","volume":"199","author":"Haney","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2014.11.018_bb0040","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/sj.npp.1301578","article-title":"Acute physiological and behavioral effects of intranasal methamphetamine in humans","volume":"33","author":"Hart","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2014.11.018_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/add.12636","article-title":"Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use","author":"Heinzerling","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.pbb.2014.11.018_bb0050","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/j.1552-4604.1997.tb04361.x","article-title":"Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers","volume":"37","author":"Hsyu","year":"1997","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pbb.2014.11.018_bb0065","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.jcp.0000144893.29987.e5","article-title":"Effects of naltrexone on the subjective response to amphetamine in healthy volunteers","volume":"24","author":"Jayaram-Lindstr\u00f6m","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2014.11.018_bb0055","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1176\/appi.ajp.2008.08020304","article-title":"Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial","volume":"165","author":"Jayaram-Lindstr\u00f6m","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2014.11.018_bb0060","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/sj.npp.1301572","article-title":"Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence","volume":"33","author":"Jayaram-Lindstr\u00f6m","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2014.11.018_bb0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/FBP.0b013e3283423d55","article-title":"Naltrexone decreases D-amphetamine and ethanol self-administration in rhesus monkeys","volume":"22","author":"Jimenez-Gomez","year":"2011","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2014.11.018_bb0075","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1360-0443.2011.03706.x","article-title":"Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans","volume":"107","author":"Kirkpatrick","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.pbb.2014.11.018_bb0080","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1007\/s00213-014-3449-x","article-title":"Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users","volume":"231","author":"Marks","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2014.11.018_bb0085","first-page":"15","article-title":"Bioequivalence, dose-proportionality and pharmacokinetics of naltrexone after oral administration","volume":"45","author":"Meyer","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2014.11.018_bb0090","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00213-005-0102-8","article-title":"Safety of intravenous methamphetamine administration during treatment with bupropion","volume":"182","author":"Newton","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2014.11.018_bb0095","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.npp.1300979","article-title":"Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving","volume":"31","author":"Newton","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2014.11.018_bb0100","series-title":"The economic cost of methamphetamine use in the United States, 2005","author":"Nicosia","year":"2009"},{"key":"10.1016\/j.pbb.2014.11.018_bb0105","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0022-3565(25)11160-9","article-title":"Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports","volume":"261","author":"Oliveto","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2014.11.018_bb0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/clpt.2010.65","article-title":"Cross-validation of a new procedure for early screening of smoking cessation medications in humans","volume":"88","author":"Perkins","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pbb.2014.11.018_bb0115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archpsyc.63.2.219","article-title":"Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population","volume":"63","author":"Poling","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2014.11.018_bb0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drugalcdep.2008.09.006","article-title":"Bupropion attenuates methamphetamine self-administration in adult male rats","volume":"100","author":"Reichel","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2014.11.018_bb0125","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1176\/ajp.2006.163.11.1993","article-title":"Contingency management for the treatment of methamphetamine use disorders","volume":"163","author":"Roll","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2014.11.018_bb0130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/jpet.102.048439","article-title":"Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans","volume":"306","author":"Rush","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2014.11.018_bb0135","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/JCP.0b013e3181d21967","article-title":"Cocaine choice in humans during d-amphetamine maintenance","volume":"30","author":"Rush","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2014.11.018_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0022432","article-title":"Comparison of the effects of methamphetamine, bupropion, and methylphenidate on the self-administration of methamphetamine by rhesus monkeys","volume":"19","author":"Schindler","year":"2011","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2014.11.018_bb0145","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/JCP.0b013e318221b2db","article-title":"Discriminative-stimulus, subject-rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole","volume":"31","author":"Sevak","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2014.11.018_bb0150","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.03.010","article-title":"Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence","volume":"96","author":"Shoptaw","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2014.11.018_bb0165","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1586\/17512433.2014.909283","article-title":"Combination pharmacotherapies for stimulant use disorder: A review of clinical findings and recommendations for future research","volume":"7","author":"Stoops","year":"2014","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.pbb.2014.11.018_bb0175","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/0306624X04273438","article-title":"Methamphetamine use in nonurban and urban drug court clients","volume":"49","author":"Stoops","year":"2005","journal-title":"Int J Offender Ther Comp Criminol"},{"issue":"Suppl. 4","key":"10.1016\/j.pbb.2014.11.018_bb0170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/02791072.2007.10399902","article-title":"Kentucky rural stimulant use: a comparison of methamphetamine and other stimulant users","author":"Stoops","year":"2007","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.pbb.2014.11.018_bb0160","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1360-0443.2011.03766.x","article-title":"Influence of acute bupropion pre-treatment on the effects of intranasal cocaine","volume":"107","author":"Stoops","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.pbb.2014.11.018_bb0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pnpbp.2013.08.007","article-title":"Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans","volume":"47","author":"Stoops","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2014.11.018_bb0180","series-title":"NSDUH Series H-46, HHS Publication No. (SMA) 13-4795","article-title":"Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings","author":"Substance Abuse and Mental Health Services Administration","year":"2013"},{"key":"10.1016\/j.pbb.2014.11.018_bb0185","series-title":"Treatment Episode Data Set (TEDS): 2001\u20132011. National Admissions to Substance Abuse Treatment Services","article-title":"Center for Behavioral Health Statistics and Quality","author":"Substance Abuse and Mental Health Services Administration","year":"2013"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305714003189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305714003189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:50:55Z","timestamp":1747173055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305714003189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":37,"alternative-id":["S0091305714003189"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2014.11.018","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2014.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}